Behrens-Baumann W, König U, Schröder K, Hansmann I, Langenbeck U
Graefes Arch Clin Exp Ophthalmol. 1982;218(1):21-4. doi: 10.1007/BF02134094.
A thirty-six years old man from an inbred family with the typical clinical picture of Atrophia gyrata chorioideae et retinae was found to have hyperornithinemia and a partial deficiency of ornithin-ketoacid-transaminase activity. The residual activity was stimulated in vitro by high concentrations of pyridoxal phosphate. We have initiated a therapeutic study with vitamin B6 per os accordingly. Comparitively low doses may be sufficient for long term treatment. The necessity to start therapy early in life is emphazised. Possible mechanisms of the pathogenesis of Atrophia gyrata are discussed.
一名来自近亲家庭的36岁男性,具有典型的脉络膜视网膜回旋性萎缩临床症状,被发现患有高鸟氨酸血症和鸟氨酸 - 酮酸转氨酶活性部分缺乏。体外实验中,高浓度的磷酸吡哆醛可刺激残余活性。因此,我们已开始口服维生素B6进行治疗研究。相对较低的剂量可能足以进行长期治疗。强调了在生命早期开始治疗的必要性。文中还讨论了脉络膜视网膜回旋性萎缩发病机制的可能原因。